Literature DB >> 11549644

Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome.

K Landin-Wilhelmsen1, I Bryman, L Wilhelmsen.   

Abstract

Turner syndrome (TS) is caused by an X chromosome aberration and is characterized by endogenous estrogen deficiency secondary to ovarian dysgenesis and short stature. Our aim was to study the prevalence of cardiovascular malformations and cardiovascular risk factors (blood pressure, blood lipids and glucose, coagulation factors, social factors, smoking habits) in adults with Turner syndrome in comparison with a female random population sample. One hundred women with Turner syndrome (aged 16-71 yr) underwent physical examination, echocardiography, electrocardiography, and blood sampling. Seventy-one of them were matched for age [mean age, 33.7 +/- 11 yr (range, 25-64)] with a random population sample (n = 213) of women [mean age, 34.8 +/- 9 yr (range, 25-64)] from the World Health Organization's Monitoring of Trends and Determinants in Cardiovascular Diseases Project, Göteborg. Six percent of Turner syndrome women were smokers compared with 25% in the population (P < 0.001). Turner syndrome women were relatively heavier and had a lower degree of leisure time physical activity than controls (P < 0.001). Diabetes and treatment for hypertension were present in 3 and 22% among Turner syndrome women vs. 2% (not significant) and 3% (P < 0.001) in controls, respectively. Cardiovascular malformations were found among 17% in Turner syndrome women (45,X dominated) vs. 0.5% in controls (P < 0.001). Systolic but not diastolic blood pressure was higher in Turner syndrome women. No differences were seen in serum total cholesterol, high- or low-density lipoprotein cholesterol, triglycerides, lipoprotein (a), or plasma fibrinogen concentrations between patients and controls. Diabetes or hypertension was not related to karyotype. In conclusion, congenital cardiovascular malformations were frequent. Most cardiovascular risk factors (glucose and lipid levels, fibrinogen, smoking habits) were not increased, but hypertension was more common in Turner syndrome women.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549644     DOI: 10.1210/jcem.86.9.7818

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

Review 1.  Cardiovascular disease and primary ovarian insufficiency.

Authors:  Melissa Wellons
Journal:  Semin Reprod Med       Date:  2011-10-03       Impact factor: 1.303

2.  Failure of Marfan anatomic criteria to predict risk of aortic dissection in Turner syndrome: necessity of specific adjusted risk thresholds.

Authors:  Juan-Pablo Maureira; Fabrice Vanhuyse; Malik Lekehal; Thierry Hubert; Charlène Vigouroux; Marie-Françoise Mattei; Daniel Grandmougin; Jean-Pierre Villemot
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-01-26

Review 3.  Disorders of Sexual Development in Adult Women.

Authors:  Veronica Gomez-Lobo; Anne-Marie Amies Oelschlager
Journal:  Obstet Gynecol       Date:  2016-11       Impact factor: 7.661

Review 4.  Hypertension in Children and Adolescents with Turner Syndrome (TS), Neurofibromatosis 1 (NF1), and Williams Syndrome (WS).

Authors:  Ramya Sivasubramanian; Kevin E Meyers
Journal:  Curr Hypertens Rep       Date:  2021-03-29       Impact factor: 5.369

5.  Spontaneous pregnancies in a Turner syndrome woman with Y-chromosome mosaicism.

Authors:  Kerstin Landin-Wilhelmsen; Inger Bryman; Charles Hanson; Lars Hanson
Journal:  J Assist Reprod Genet       Date:  2004-06       Impact factor: 3.412

Review 6.  A comprehensive view of sex-specific issues related to cardiovascular disease.

Authors:  Louise Pilote; Kaberi Dasgupta; Veena Guru; Karin H Humphries; Jennifer McGrath; Colleen Norris; Doreen Rabi; Johanne Tremblay; Arsham Alamian; Tracie Barnett; Jafna Cox; William Amin Ghali; Sherry Grace; Pavel Hamet; Teresa Ho; Susan Kirkland; Marie Lambert; Danielle Libersan; Jennifer O'Loughlin; Gilles Paradis; Milan Petrovich; Vicky Tagalakis
Journal:  CMAJ       Date:  2007-03-13       Impact factor: 8.262

7.  Impact of Absorption and Transport on Intelligent Therapeutics and Nano-scale Delivery of Protein Therapeutic Agents.

Authors:  Nicholas A Peppas; Daniel A Carr
Journal:  Chem Eng Sci       Date:  2009-11-16       Impact factor: 4.311

8.  Cardiovascular anomalies in children and young adults with Ullrich-Turner syndrome the Erlangen experience.

Authors:  Thomas M K Völkl; Karin Degenhardt; Andreas Koch; Diemud Simm; Helmuth G Dörr; Helmut Singer
Journal:  Clin Cardiol       Date:  2005-02       Impact factor: 2.882

Review 9.  Partial anomalous pulmonary vein connection: an underestimated cardiovascular defect in Ullrich-Turner syndrome.

Authors:  Susanne M Bechtold; Robert Dalla Pozza; Axel Becker; Anette Meidert; Christoph Döhlemann; Hans Peter Schwarz
Journal:  Eur J Pediatr       Date:  2004-01-10       Impact factor: 3.183

10.  Delayed β-cell response and glucose intolerance in young women with Turner syndrome.

Authors:  Britta E Hjerrild; Jens J Holst; Claus B Juhl; Jens S Christiansen; Ole Schmitz; Claus H Gravholt
Journal:  BMC Endocr Disord       Date:  2011-03-15       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.